LIGAND PHARMACEUTICALS INCORPORATED Proceeds from Issuance Initial Public Offering
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Proceeds from Issuance Initial Public Offering of $2.60 million for the 1-month period ending 2012-08-31, per its 10-Q/A filed 2012-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2012-11-14
- 2012-08-31: Proceeds from Issuance Initial Public Offering 1 month $2.60M.
| Period end | Proceeds from Issuance Initial Public Offering 1 month |
|---|---|
| 2012-08-31 | $2.60M 10-Q/A · filed 2012-11-14 |